Mon, March 28, 2022
Sun, March 27, 2022
Fri, March 25, 2022
Thu, March 24, 2022
Wed, March 23, 2022
Tue, March 22, 2022
Mon, March 21, 2022
Sun, March 20, 2022
Fri, March 18, 2022
Thu, March 17, 2022
Wed, March 16, 2022
Tue, March 15, 2022

Amit Hazan Maintained (BVS) at Hold with Decreased Target to $17 on, Mar 21st, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-17-on-mar-21st-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Amit Hazan of Goldman Sachs, Maintained "Bioventus Inc." (BVS) at Hold with Decreased Target from $19 to $17 on, Mar 21st, 2022.

Amit has made no other calls on BVS in the last 4 months.



There are 2 other peers that have a rating on BVS. Out of the 2 peers that are also analyzing BVS, 0 agree with Amit's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Amit


  • Alexander Nowak of "Craig-Hallum" Initiated at Strong Buy and Held Target at $30 on, Tuesday, March 15th, 2022
  • Drew Ranieri of "Morgan Stanley" Maintained at Buy with Decreased Target to $18 on, Friday, March 11th, 2022

Publication Contributing Sources